SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023496
Filing Date
2022-11-09
Accepted
2022-11-09 07:00:43
Documents
54
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-20220930.htm   iXBRL 10-Q 1417688
2 EX-31.1 nerv-ex31_1.htm EX-31.1 19671
3 EX-31.2 nerv-ex31_2.htm EX-31.2 19004
4 EX-32.1 nerv-ex32_1.htm EX-32.1 17100
  Complete submission text file 0000950170-22-023496.txt   5040439

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nerv-20220930.xsd EX-101.SCH 38503
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nerv-20220930_lab.xml EX-101.LAB 305444
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nerv-20220930_cal.xml EX-101.CAL 27937
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nerv-20220930_pre.xml EX-101.PRE 233092
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nerv-20220930_def.xml EX-101.DEF 130449
48 EXTRACTED XBRL INSTANCE DOCUMENT nerv-20220930_htm.xml XML 786385
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 221370600
SIC: 2834 Pharmaceutical Preparations